PharmaLogic and Ratio Therapeutics Expand Manufacturing Collaboration for Targeted Alpha Therapy Candidate AQST Q1 2026 Earnings Narrowing Losses with EPS Beat of Nearly 50 Jobless Claims Drop to Lowest Level Since MidMay Signaling Labor Market Resilience